The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review-Reference-Cited by-同舟云学术

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review

Published:2003-01 Issue:1 Volume:9 Page:4-37
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hahn Theresa,Wingard John R.,Anderson Kenneth C.,Bensinger William I.,Berenson James R.,Brozeit Greg,Carver Joseph R.,Kyle Robert A.,McCarthy Philip L.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference198 articles.

1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence based review;Hahn;Biol Blood Marrow Transplant,2001

2. Policy statement regarding the methodology of evidence-based reviews in evaluating the role of blood and marrow transplantation in the therapy of selected diseases;Jones;Biol Blood Marrow Transplant,2000

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

4. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997

5. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group;Lenhoff;Blood,2000

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collection of Hematopoietic Stem Cells and Cell Therapy Products;Comprehensive Hematology and Stem Cell Research;2024

2. Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review;Frontiers in Oncology;2022-10-03

3. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients;Transfusion and Apheresis Science;2021-08

4. Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee;Transplantation and Cellular Therapy;2021-05

5. Bortezomib enhances G-CSF-induced hematopoietic stem cell mobilization by decreasing CXCL12 levels and increasing vascular permeability;Experimental Hematology;2021-05